We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$14.4B
AUM Growth
-$17.7M
Cap. Flow
-$611M
Cap. Flow %
-4.24%
Top 10 Hldgs %
13.47%
Holding
2,887
New
161
Increased
708
Reduced
1,103
Closed
120

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$17.7M
2
AVGO icon
Broadcom
AVGO
+$9.26M
3
WMB icon
Williams Companies
WMB
+$8M
4
KMI icon
Kinder Morgan
KMI
+$7.12M
5
NRG icon
NRG Energy
NRG
+$6.75M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$38M
2
MET icon
MetLife
MET
+$36.4M
3
AAPL icon
Apple
AAPL
+$22.5M
4
CB icon
Chubb
CB
+$20.4M
5
XOM icon
ExxonMobil
XOM
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Financials 12.79%
3 Energy 12.37%
4 Healthcare 12.15%
5 Industrials 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPT
1701
DELISTED
Gramercy Property Trust
GPT
$603K ﹤0.01%
33,204
+16,938
+104% +$282K
BRLI
1702
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$603K ﹤0.01%
19,949
– –
ANR
1703
DELISTED
Alpha Natural Resources Inc
ANR
$602K ﹤0.01%
162,280
-190,211
-54% -$766K
JAZZ icon
1704
Jazz Pharmaceuticals
JAZZ
$16B
$599K ﹤0.01%
4,105
+538
+15% +$74.6K
LAB icon
1705
Standard BioTools
LAB
$312M
$599K ﹤0.01%
20,378
– –
INO icon
1706
Inovio Pharmaceuticals
INO
$93M
$598K ﹤0.01%
+4,608
New +$544K
AZTA icon
1707
Azenta
AZTA
$1.49B
$597K ﹤0.01%
55,393
-998
-2% -$10.1K
SWBI icon
1708
Smith & Wesson
SWBI
$636M
$597K ﹤0.01%
53,419
-8,294
-13% -$98K
FCF icon
1709
First Commonwealth Financial
FCF
$2.18B
$596K ﹤0.01%
64,611
-16,122
-20% -$141K
SHEN icon
1710
Shenandoah Telecom
SHEN
$721M
$596K ﹤0.01%
39,130
– –
CVCO icon
1711
Cavco Industries
CVCO
$4.6B
$595K ﹤0.01%
6,972
+409
+6% +$31.8K
UEIC icon
1712
Universal Electronics
UEIC
$66.6M
$595K ﹤0.01%
12,173
– –
ACHN
1713
DELISTED
Achillion Pharmaceuticals
ACHN
$595K ﹤0.01%
78,646
+3,553
+5% +$14.2K
STNR
1714
DELISTED
STEINER LEISURE LTD
STNR
$595K ﹤0.01%
12,101
– –
CHCO icon
1715
City Holding Co
CHCO
$2.08B
$594K ﹤0.01%
13,171
– –
AMSF icon
1716
AMERISAFE
AMSF
$504M
$592K ﹤0.01%
14,557
– –
ARI
1717
Apollo Commercial Real Estate
ARI
$885M
$591K ﹤0.01%
35,832
+2,807
+8% +$46.9K
GEOS icon
1718
Geospace Technologies
GEOS
$67.9M
$591K ﹤0.01%
10,733
– –
MFRM
1719
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
$591K ﹤0.01%
12,382
– –
FURX
1720
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$589K ﹤0.01%
5,551
– –
HAYN
1721
DELISTED
Haynes International, Inc.
HAYN
$587K ﹤0.01%
10,369
– –
VMW
1722
DELISTED
VMware, Inc
VMW
$586K ﹤0.01%
6,056
+174
+3% +$16.9K
CONE
1723
DELISTED
CyrusOne Inc Common Stock
CONE
$586K ﹤0.01%
23,548
+2,683
+13% +$58.8K
KRA
1724
DELISTED
Kraton Corporation
KRA
$586K ﹤0.01%
26,172
– –
NEWP
1725
DELISTED
NEWPORT CORP
NEWP
$586K ﹤0.01%
31,649
– –
67 68
69
70 71

Similar funds

RM
Rudius Management New York $358M AUM 12.23% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q2 2014 Portfolio in Review

As of Q2 2014, Metropolitan Life Insurance Company (MetLife) held 2,887 positions worth $14.4B, down 0.12% from $14.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $611M in Q2 2014, closing 120 positions and reducing 1,103 holdings. Its most notable exit was Monsanto Co, an estimated $38M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Energy.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $17.1M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2014 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 150,000 shares worth $17.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to Broadcom in Q2 2014, an estimated $9.26M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2014 reduction was Apple, cutting an estimated $22.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Monsanto Co in Q2 2014, selling an estimated $38M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 13% of its $14.4B portfolio in Q2 2014.
  • Metropolitan Life Insurance Company (MetLife) opened 161 new positions and closed 120 in Q2 2014.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 0.12% quarter-over-quarter to $14.4B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2014, filed 31 Jul 2014.